دورية أكاديمية
أعرض في EDS

A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study

التفاصيل البيبلوغرافية
العنوان: A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study
المؤلفون: Koot, David, Goh, Paul Soo Chye, Lim, Robyn Su May, Tian, Yubing, Yau, Teng Yan, Tan, Ngiap Chuan, Finkelstein, Eric Andrew
المصدر: JMIR mHealth and uHealth, Vol 7, Iss 5, p e12965 (2019)
بيانات النشر: JMIR Publications, 2019.
سنة النشر: 2019
المجموعة: LCC:Information technology
LCC:Public aspects of medicine
مصطلحات موضوعية: Information technology, T58.5-58.64, Public aspects of medicine, RA1-1270
الوصف: BackgroundSingapore’s current prevalence of diabetes exceeds 13.6%. Although lifestyle modification can be effective for reducing the risks for complications of type 2 diabetes mellitus (T2DM), traditional lifestyle interventions are often difficult to administer in the primary care setting due to limited resources. Mobile health apps can address these limitations by offering low-cost, adaptable, and accessible platforms for disseminating lifestyle management interventions. ObjectiveUsing the RE-AIM evaluation framework, this study assessed the potential effectiveness and feasibility of GlycoLeap, a mobile lifestyle management program for people with T2DM, as an add-on to standard care. MethodsThis single-arm feasibility study recruited 100 patients with T2DM and glycated hemoglobin (HbA1c) levels of ≥7.5% from a single community health care facility in Singapore. All participants were given access to a 6-month mobile lifestyle management program, GlycoLeap, comprising online lessons and the Glyco mobile phone app with a health coaching feature. The GlycoLeap program was evaluated using 4 relevant dimensions of the RE-AIM framework: (1) reach (percentage who consented to participate out of all patients approached), (2) effectiveness (percentage point change in HbA1c [primary outcome] and weight loss [secondary outcome]), (3) implementation (program engagement as assessed by various participatory metrics), and (4) maintenance (postintervention user satisfaction surveys to predict the sustainability of GlycoLeap). Participants were assessed at baseline and at follow-up (≥12 weeks after starting the intervention). ResultsA total of 785 patients were approached of whom 104 consented to participate, placing the reach at 13.2%. Four were excluded after eligibility screening, and 100 patients were recruited. Program engagement (implementation) started out high but decreased with time for all evaluated components. Self-reported survey data suggest that participants monitored their blood glucose on more days in the past week at follow-up compared to baseline (P
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2291-5222
Relation: http://mhealth.jmir.org/2019/5/e12965/; https://doaj.org/toc/2291-5222
DOI: 10.2196/12965
URL الوصول: https://doaj.org/article/abf0b259f04d4d27b5a65e98ae62d5a4
رقم الأكسشن: edsdoj.bf0b259f04d4d27b5a65e98ae62d5a4
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:22915222
DOI:10.2196/12965